Bioproduction laboratories at French contract manufacturer Cell for Cure could soon be crafting Novartis' cancer cell therapies for clinical and potential commercial use, pending a technology transfer that's planned for 2019.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,